Privia Health Group (NASDAQ:PRVA) Hits New 52-Week High – Time to Buy?

Privia Health Group, Inc. (NASDAQ:PRVA) shares reached a new 52-week high during trading on Thursday . The company traded as high as $25.80 and last traded at $25.67, with a volume of 211418 shares changing hands. The stock had previously closed at $24.06.

Analyst Upgrades and Downgrades

A number of research analysts have commented on PRVA shares. Canaccord Genuity Group upped their price target on Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Friday. JMP Securities reaffirmed a “market outperform” rating and set a $26.00 price target on shares of Privia Health Group in a research report on Friday, February 14th. Barclays upped their price target on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, November 8th. Stephens reaffirmed an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. Finally, Truist Financial upped their price target on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, November 8th. One investment analyst has rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Privia Health Group has an average rating of “Buy” and an average price target of $26.59.

Privia Health Group Trading Down 1.9 %

The company has a market cap of $3.00 billion, a PE ratio of 249.72, a P/E/G ratio of 3.47 and a beta of 0.87. The firm has a 50 day moving average of $22.40 and a two-hundred day moving average of $20.59.

Institutional Trading of Privia Health Group

Hedge funds and other institutional investors have recently made changes to their positions in the stock. First Horizon Advisors Inc. grew its stake in shares of Privia Health Group by 53.8% in the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after buying an additional 632 shares during the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after buying an additional 2,350 shares during the last quarter. Financial Management Professionals Inc. purchased a new stake in shares of Privia Health Group in the 4th quarter worth approximately $51,000. Quarry LP boosted its stake in Privia Health Group by 344.6% during the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after purchasing an additional 2,533 shares during the last quarter. Finally, KBC Group NV boosted its stake in Privia Health Group by 34.6% during the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after purchasing an additional 871 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.